- recruitingTherapeutic confirmatory (Phase III)
A three-year, multi-center, double-blind, extension study to evaluate the long-term safety and efficacy of ligelizumab in patients who completed ligelizumab’s Phase III studies in food allergy
This three-year study is looking at a new medicine called ligelizumab for food allergy. It's checking how safe it is and how well it works over a long time in people who have already taken part in earlier studies for this medicine.
Netherlands · France · Spain - recruitingNA
Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity
This study aims to improve how we diagnose food allergies and sensitivities. Researchers are looking at samples from the gut (like biopsies) to find better ways to tell if someone has a food allergy. They will compare these results with blood tests to get a clearer picture.
Germany - recruiting
EPAP, Interviewstudy
Researchers are studying why some people with food allergies have repeated severe reactions (anaphylaxis). They want to understand if certain foods are more likely to cause this, and how people manage their allergies. Participants will answer surveys online for two years to help improve care for future patients.
Germany - recruiting
Observatory of the Lille Paediatric Allergy Unit
This study at Saint Vincent Hospital in Lille, France, observes children under 16 with food allergies. It collects information about those starting a treatment called oral immunotherapy for allergens like nuts, milk, or eggs, to understand how well it works and any side effects.
France